Physician profile
Gary A Cook
NPI 1366653503
$9,398.81
in general payments reported to CMS, 2019-2025
15 companies · $2,522 in 2025
The $2,522 reported for 2025 was more than what 97% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $489 · 2022: $280 · 2023: $1,158 · 2024: $4,949 · 2025: $2,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,277 · Travel and Lodging: $3,207 · Consulting Fee: $2,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,277.31 |
| Travel and Lodging | $3,207.12 |
| Consulting Fee | $2,145.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,963.32 | 2023-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Maquet Cardiovascular L.L.C. | $2,313.84 | 2024-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Abiomed | $1,351.40 | 2022-2025 | Impella |
| Getinge USA Sales, LLC | $747.62 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Edwards Lifesciences Corporation | $486.11 | 2021-2025 | |
| Haemonetics Corporation | $96.57 | 2023 | Teg6s Hemostasis System |
| Takeda Pharmaceuticals U.S.A., INC. | $83.96 | 2025 | Livtencity |
| Becton, Dickinson and Company | $77.46 | 2024 | |
| Ethicon US, LLC | $69.62 | 2021-2022 | |
| Baxter Healthcare | $49.66 | 2025 | Preveleak |
| Boston Scientific Corporation | $48.89 | 2022 | |
| Biotronik INC. | $37.96 | 2024-2025 | Biomonitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.03 | 2021 | |
| Davol INC. | $26.26 | 2023 | |
| Abbott Laboratories | $16.11 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.